Lee Ainslie Becton Dickinson & CO Transaction History

Maverick Capital LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $501,638 - $577,216	-2,160 Reduced 49.58%	2,197 $535,000
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $75,195 - $83,659	-295 Reduced 6.34%	4,357 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $578,334 - $643,666	2,426 Added 108.98%	4,652 $1.23 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $511,334 - $577,313	2,226 New	2,226 $551,000
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $1.07 Million - $1.19 Million	-4,819 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $1.04 Million - $1.33 Million	4,819 New	4,819 $1.12 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $2.89 Million - $3.64 Million	-14,110 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $1.87 Million - $2.05 Million	-8,010 Reduced 36.21%	14,110 $3.68 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $4.6 Million - $5.17 Million	22,120 New	22,120 $5.3 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $2.1 Million - $2.46 Million	-10,223 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$189.0 - $222.64 $1.93 Million - $2.28 Million	10,223	10,223 $2.19 Million

1,768

255M

681K

857K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.